| [1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
| [2] |
Yuan Jian, Huang Yanhua.
Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer
[J]. Journal of International Oncology, 2024, 51(6): 338-343.
|
| [3] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
| [4] |
Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.
Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer
[J]. Journal of International Oncology, 2024, 51(5): 286-291.
|
| [5] |
Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.
Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor
[J]. Journal of International Oncology, 2024, 51(5): 298-302.
|
| [6] |
Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng.
Imaging diagnosis， pathological upgrade， and imaging technology progress of ductal carcinoma in situ of the breast
[J]. Journal of International Oncology, 2024, 51(3): 166-169.
|
| [7] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
| [8] |
Peng Qin, Cai Yuting, Wang Wei.
Advances on KPNA2 in liver cancer
[J]. Journal of International Oncology, 2024, 51(3): 181-185.
|
| [9] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
| [10] |
Jin Xudong, Chen Zhongjian, Mao Weimin.
Research progress on the role of MTAP in malignant mesothelioma
[J]. Journal of International Oncology, 2024, 51(2): 99-104.
|
| [11] |
He Jiahui, Hu Qinyong.
Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data
[J]. Journal of International Oncology, 2024, 51(1): 29-36.
|
| [12] |
Huang Zhen, Chen Yongshun.
Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma
[J]. Journal of International Oncology, 2024, 51(1): 59-64.
|
| [13] |
Wang Jing, Xu Wenting.
Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm
[J]. Journal of International Oncology, 2023, 50(9): 520-526.
|
| [14] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
| [15] |
Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.
Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）
[J]. Journal of International Oncology, 2023, 50(7): 385-397.
|
